Stephen Thau

Stephen Thau

Morrison & Foerster LLP

Contact  |  View Bio  |  RSS

Latest Posts › OTC

Share:

MoFo BioMeter - Volume 2, Issue 2: May 2013 - Flat BioMeter Value and Decline in Deal Volume are Hallmarks of Q1

The Morrison & Foerster BioMeter for the first quarter of 2013 shows a flat quarter for BioMeter value and a decline in dealmaking activity. A small number of large deals dominate an otherwise quiet quarter. In the...more

5/31/2013 - Biotechnology OTC Pharmaceutical Prescription Drugs Valuation

1 Results
|
View per page
Page: of 1